BRPI0515794A - processos para avaliar pacientes com leucemia mielóide aguda - Google Patents
processos para avaliar pacientes com leucemia mielóide agudaInfo
- Publication number
- BRPI0515794A BRPI0515794A BRPI0515794-3A BRPI0515794A BRPI0515794A BR PI0515794 A BRPI0515794 A BR PI0515794A BR PI0515794 A BRPI0515794 A BR PI0515794A BR PI0515794 A BRPI0515794 A BR PI0515794A
- Authority
- BR
- Brazil
- Prior art keywords
- patient
- processes
- myeloid leukemia
- therapy
- acute myeloid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2565/00—Nucleic acid analysis characterised by mode or means of detection
- C12Q2565/50—Detection characterised by immobilisation to a surface
- C12Q2565/501—Detection characterised by immobilisation to a surface being an array of oligonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63726504P | 2004-12-17 | 2004-12-17 | |
| US67011605P | 2005-04-11 | 2005-04-11 | |
| US74118005P | 2005-12-01 | 2005-12-01 | |
| PCT/US2005/046100 WO2006066240A2 (fr) | 2004-12-17 | 2005-12-19 | Procede d'estimation de patients souffrant d'une leucemie myeloide aigue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0515794A true BRPI0515794A (pt) | 2008-08-05 |
Family
ID=36588648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0515794-3A BRPI0515794A (pt) | 2004-12-17 | 2005-12-19 | processos para avaliar pacientes com leucemia mielóide aguda |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1836313A4 (fr) |
| JP (1) | JP2008523822A (fr) |
| KR (1) | KR20070099564A (fr) |
| AU (1) | AU2005316291A1 (fr) |
| BR (1) | BRPI0515794A (fr) |
| CA (1) | CA2589055A1 (fr) |
| IL (1) | IL183555A0 (fr) |
| MX (1) | MX2007007401A (fr) |
| WO (1) | WO2006066240A2 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100617467B1 (ko) * | 2005-09-27 | 2006-09-01 | 디지탈 지노믹스(주) | 급성 골수성 백혈병 환자의 항암제 치료 반응성 예측용마커 |
| CA2674895A1 (fr) * | 2007-01-31 | 2008-08-07 | The Ohio State University Research Foundation | Methodes et compositions a base de micro-arn pour le diagnostic, le pronostic et le traitement de la leucemie aigue myeloide (lam) |
| EP2056110A1 (fr) * | 2007-10-31 | 2009-05-06 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Biomarqueur pour prédire une réponse à un traitement par un anti-TNF-alpha |
| EP2272028A1 (fr) * | 2008-04-25 | 2011-01-12 | Koninklijke Philips Electronics N.V. | Classification de données d'échantillon |
| US7736861B1 (en) * | 2009-10-19 | 2010-06-15 | Aveo Pharmaceuticals, Inc. | Tivozanib response prediction |
| WO2012007783A1 (fr) * | 2010-07-13 | 2012-01-19 | Institut Gustave Roussy | Trousses et procédés de détection de la capacité à induire une mort cellulaire cancéreuse immunogène chez un patient |
| WO2011131246A1 (fr) * | 2010-04-22 | 2011-10-27 | Institut Gustave Roussy | Composés et utilisations de ceux-ci pour induire la mort d'une cellule cancéreuse immunogène chez un sujet |
| EP2913405B1 (fr) | 2010-07-27 | 2016-11-09 | Genomic Health, Inc. | Procédé d'utilisation de l'expression génique pour déterminer le pronostic du cancer de la prostate |
| KR101660322B1 (ko) * | 2011-04-28 | 2016-09-29 | 아크레이 가부시키가이샤 | ＮＰＭ1 유전자의 ｅｘｏｎ12 변이의 검출용 프로브 및 그 용도 |
| KR101922761B1 (ko) * | 2015-11-18 | 2018-11-27 | 가톨릭대학교 산학협력단 | 급성 골수성 백혈병 진단을 위한 ｃ―Ｋｉｔ 돌연변이 실시간 정량 ＰＣＲ 분석법 및 이의 이용 |
-
2005
- 2005-12-19 MX MX2007007401A patent/MX2007007401A/es unknown
- 2005-12-19 KR KR1020077013783A patent/KR20070099564A/ko not_active Application Discontinuation
- 2005-12-19 JP JP2007547020A patent/JP2008523822A/ja active Pending
- 2005-12-19 CA CA002589055A patent/CA2589055A1/fr not_active Abandoned
- 2005-12-19 EP EP05854761A patent/EP1836313A4/fr not_active Withdrawn
- 2005-12-19 BR BRPI0515794-3A patent/BRPI0515794A/pt not_active IP Right Cessation
- 2005-12-19 AU AU2005316291A patent/AU2005316291A1/en not_active Abandoned
- 2005-12-19 WO PCT/US2005/046100 patent/WO2006066240A2/fr active Application Filing
-
2007
- 2007-05-30 IL IL183555A patent/IL183555A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006066240A2 (fr) | 2006-06-22 |
| JP2008523822A (ja) | 2008-07-10 |
| EP1836313A4 (fr) | 2010-06-30 |
| KR20070099564A (ko) | 2007-10-09 |
| AU2005316291A1 (en) | 2006-06-22 |
| EP1836313A2 (fr) | 2007-09-26 |
| IL183555A0 (en) | 2007-09-20 |
| WO2006066240A8 (fr) | 2006-09-08 |
| MX2007007401A (es) | 2007-10-08 |
| CA2589055A1 (fr) | 2006-06-22 |
| WO2006066240A3 (fr) | 2008-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0515794A (pt) | processos para avaliar pacientes com leucemia mielóide aguda | |
| BRPI0503418A (pt) | prognóstico para malignidade hematológica | |
| BRPI0502433A (pt) | métodos para avaliação e tratamento de cáncer | |
| Murray et al. | Tumor angiogenesis as a prognostic factor in laryngeal cancer | |
| DE60126592D1 (de) | Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs | |
| ATE541053T1 (de) | Verfahren und zusammensetzungen zur behandlung von nichtkleinzelligem lungenkrebs | |
| ATE540319T1 (de) | Verfahren für die bestimmung von fk506 | |
| ATE406834T1 (de) | System zur überwachung der konzentration von analyten in körperflüssigkeiten | |
| BR9808313A (pt) | Métodos para determinar a predisposição de um paciente à doença arterial coronariana e kit para previsão de doença arterial coronariana | |
| DE60233949D1 (de) | Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon | |
| ATE364089T1 (de) | Reagenzien und methoden zum nachweis von erkrankungen der brust | |
| DK3059322T3 (da) | Genekspressionsmarkører for brystcancerprognose | |
| DE60324925D1 (de) | Ace2-aktivierung zur behandlung von herz, lungen, und nierenkrankheit und bluthochdruck | |
| WO2009015050A3 (fr) | Profil d'expression génique pour prédire la survie d'une patiente atteinte d'un cancer des ovaires | |
| WO2008073629A3 (fr) | Predicteurs bifonctionnels de sensibilite et de resistance a un traitement anti-cancereux | |
| CY1110076T1 (el) | Μεθοδος για τον καθορισμο της δεκτικοτητας σε αναστολεις chk1 | |
| DE60222590D1 (de) | Methoden zur feststellung von akute myeloischen leukämie | |
| DK1816214T3 (da) | Fremgangsmåde og sammensætninger til perioperativ, genomisk profilering | |
| ATE496635T1 (de) | Verfahren und zusammensetzungen zur hemmung, prävention oder verringerung des tumorzellwachstums bei patienten, die gegen die antineoplastischen wirkungen einer antiöstrogen- therapie resistent sind | |
| ATE419375T1 (de) | Amplifizierung von cyp24 und anwendung dafür | |
| ATE426162T1 (de) | Verfahren zum untersuchen von kírperflussikeiten auf krebszellen sowie entsprechende analysekits | |
| CY1105566T1 (el) | Ποσοτικη διαγνωστικη αναλυση της προδιαθεσης για υπερταση | |
| MXPA05014220A (es) | Genes regulados en cancer ovarico como objetivos de pronostico y terapeuticos. | |
| DE60218843D1 (de) | Verfahren zur identifizierung von mitteln zur behandlung von diabetes | |
| ATE466938T1 (de) | Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2204 DE 02/04/2013. |